Nasdaq - Delayed Quote USD

Fidelity Disruptive Medicine Fund (FMEDX)

11.28
-0.02
(-0.18%)
At close: January 23 at 8:01:16 PM EST

Fund Summary

Normally the fund invests at least 80% of assets in securities of disruptive medicine companies. Normally it invests primarily in equity securities. Companies within the disruptive medicine theme include but are not limited to those companies that, in the Adviser's opinion, are engaged in robotic surgery, gene therapy, genomics, rare diseases, medical devices and equipment, immunotherapy, technology-based health care platforms, and consumer wellness. The fund is non-diversified.

Risk Overview

Morningstar Risk Rating
Best 1Y Total Return 10.99%
Worst 1Y Total Return --
Number of Years Up 1
Number of Years Down 1

Performance & Risk

YTD Return 4.82%
5y Average Return 0.00%
Rank in Category (ytd) 22
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.78
Morningstar Risk Rating

Risk Statistics

3 Years 5 Years 10 Years
FMEDXCategory AverageFMEDXCategory AverageFMEDXCategory Average
Alpha -7.03 0.04 -- 0.03 -- 0.07
BETA 0.78 0.01 -- 0.01 -- 0.01
Mean Annual Return 0.16 0.01 -- 0.01 -- 0.01
R-squared 57.43 0.6 -- 0.52 -- 0.5
Standard Deviation 17.66 0.21 -- 0.19 -- 0.17
Sharpe Ratio 0.03 0.01 -- 0.01 -- 0.01
Treynor Ratio -1.4 0.17 -- 0.16 -- 0.18

Related Tickers